MARCH 13, 2006

Company

IGC Pharma, Inc.

Filed

March 13, 2006

Accession Number

0001013594-06-000224

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →